Pharma AI|28 Mar 2026
Observer.com reports on unaddressed security vulnerabilities emerging within the pharmaceutical sector's adoption of AI technologies, highlighting potential gaps in data protection.
Why It Matters
Another shiny new tech, another blind spot. For European pharma, this isn't just a technical glitch; it's a ticking clock for GDPR and the EU AI Act. Your AI projects risk data breaches & fines if security isn't built-in, not bolted on. Remember the early internet?
What To Do About It
I can audit your existing AI initiatives for compliance risks and help establish a 'local-first' AI security framework, often leveraging your current Microsoft 365 investment, ensuring you're ready for EU AI Act by August 2026. Let's talk.
pharma data privacy AIpharma GDPR AIclinical trial AI automationbiotech startup AI compliancelife sciences SMB AI
